AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildavake M 1000mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Devak Formulations

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Vildavake M 1000mg/50mg Tablet

Combivir-M 1000mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps avert serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Combivir-M may be administered independently or alongside other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood glucose levels, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control and the prevention of future complications are key objectives. Maintaining the prescribed diet and exercise regimen is crucial for overall diabetes management, as lifestyle significantly impacts disease control. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia, especially when used concurrently with insulin or sulfonylureas, is a potential adverse event requiring prompt recognition and management. This medication isn't universally suitable. Prior to commencement, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals must consult their doctor before use. Interaction with other medications is possible; therefore, disclose all current medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Vildavake M 1000mg/50mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Vildavake M 1000mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildavake M 1000mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vildavake M 1000mg/50mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

Common Side effects of Vildavake M 1000mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildavake M 1000mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vildavake M 1000mg/50mg Tablet should be administered with a meal.

How Vildavake M 1000mg/50mg Tablet works:

Each Vildavake M 1000mg/50mg tablet combines two distinct anti-diabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vildavake M 1000mg/50mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vildavake M 1000mg/50mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Vildavake M 1000mg/50mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildavake M 1000mg/50mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Vildavake M 1000mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildavake M 1000mg/50mg Tablet :

Should you forget to take a Vildavake M 1000mg/50mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildavake M 1000mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildavake M 1000mg/50mg Tablet

Vildavake M 1000mg/50mg Tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildavake M 1000mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vildavake M 1000mg/50mg Tablet is contraindicated in patients allergic to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildavake M 1000mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Vildavake M 1000mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue use and seek immediate medical attention.
Prolonged use of Vildavake M 1000mg/50mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildavake M 1000mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent side effects to your physician.
Vildavake M 1000mg/50mg T...
184
MRP 213
13% off